logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Hisun Pharmaceuticals USA, Inc. drugs

    FiltersReset Filters
    11 results

    • cladribine

      (Cladribine)
      Hisun Pharmaceuticals USA, Inc.
      Usage: Cladribine Injection, USP is indicated for treating active Hairy Cell Leukemia, characterized by clinically significant anemia, neutropenia, thrombocytopenia, or related disease symptoms.

    • cladribine - cladribine injection, solution

      (Cladribine)
      Hisun Pharmaceuticals Usa, Inc.

    • dactinomycin - dactinomycin injection, powder, lyophilized, for solution

      (Dactinomycin)
      Hisun Pharmaceuticals Usa, Inc.

    • daptomycin - daptomycin injection, powder, lyophilized, for solution

      (Daptomycin)
      Hisun Pharmaceuticals Usa, Inc.

    • daunorubicin hydrochloride

      (daunorubicin hydrochloride)
      Hisun Pharmaceuticals USA, Inc.
      Usage: Daunorubicin hydrochloride injection is indicated for remission induction in adults with acute nonlymphocytic leukemia (including myelogenous, monocytic, erythroid) and in children and adults with acute lymphocytic leukemia, used in combination with other approved anticancer drugs.

    • daunorubicin hydrochloride - daunorubicin hydrochloride injection, solution

      (Daunorubicin Hydrochloride)
      Hisun Pharmaceuticals Usa, Inc.

    • levetiracetam - levetiracetam tablet, film coated, extended release

      (Levetiracetam)
      Hisun Pharmaceuticals Usa, Inc.

    • losartan potassium - losartan potassium tablet, film coated

      (Losartan Potassium)
      Hisun Pharmaceuticals Usa, Inc.

    • olanzapine - olanzapine tablet

      (Olanzapine)
      Hisun Pharmaceuticals Usa, Inc.

    • prednisolone - prednisolone tablet

      (Prednisolone)
      Hisun Pharmaceuticals Usa, Inc.